Contact
Please use this form to send email to PR contact of this press release:
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
TO:
Please use this form to send email to PR contact of this press release:
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
TO: